Clinical Trial Update: An Open-Label Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders [NA]

View source ↗

Summary

An open-label trial evaluated buspirone for anxiety in youth with autism spectrum disorders; the study has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Autism Spectrum Disorders

Drugs mentioned

• Buspirone (buspirone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Autism Spectrum Disorders, Anxiety | NA | Status: COMPLETED | Results posted: 2025-02-25